XML 13 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets	9 Months Ended
Intangible Assets	Sep. 30, 2019
Intangible Assets [Abstract]
Intangible Assets	Note 6 – Intangible Assets As of September 30, 2019, $1,223,000 was for IPR&D resulting from the Merger's preliminary purchase price allocation. This asset is not amortized. See Note 4. As of December 31, 2018, the balance of $41,692 consisted of NIH licensing fees. This balance was expensed into research and development costs during the three months ended March 31, 2019.